ClinicalTrials.gov
public full text
Public Domain
Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial
The purpose of this study is to test whether treatment with Aripiprazole leads to a reduction in methamphetamine craving and use in patients diagnosed with methamphetamine dependence. Patients presenting at the Omaha VA Medical Center for treatment of methamphetamine dependence, and meet inclusion criteria for the study will be invited to participate. Participation in the study will last for approximately 14 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Modafinil in Methamphetamine Dependence#1139204
- Aripiprazole Effects on Alcohol Reactivity and Consumption#860897
- Pilot TMS for Methamphetamine Use Disorder#883222
- Broad Effectiveness: Study With Aripiprazole#1184326
- Aripiprazole for Bipolar Disorder and Alcohol Use Disorder#852876
Record · ID 1463014
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive